Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry

Vaccine

Volumn 26, Issue 29-30, 2008, Pages 3580-3586

  Wang, L ^a,b   Suarez, D L ^c   Pantin Jackwood, M ^c   Mibayashi, M ^d   Garcia Sastre A ^d   Saif, Y M ^a,b   Lee, C W ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Influenza; Live attenuated vaccine; NS gene; NS1 protein

Indexed keywords

LIVE VACCINE; NONSTRUCTURAL PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; GENE IDENTIFICATION; GENETIC REASSORTMENT; IMMUNOHISTOCHEMISTRY; INFLUENZA; INFLUENZA VIRUS A; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; CHICKENS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; REASSORTANT VIRUSES; SEQUENCE DELETION; VACCINES, ATTENUATED; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 45049088557     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.001     Document Type: Article

References (38)

1. Palese P., and Shaw M.L. Orthomyxoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 5th ed. (2007), Lippincott Williams & Wilkins, Philadelphia 1647-1689
2. Chen W., Calvo P.A., Malide D., Gibbs J., Schubert U., Bacik I., et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7 12 (2001) 1306-1312
3. Krug R.M., and Etkind P.R. Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells. Virology 56 1 (1973) 334-348
4. Krug R.M., Yuan W., Noah D.L., and Latham A.G. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309 2 (2003) 181-189
5. Nemeroff M.E., Barabino S.M., Li Y., Keller W., and Krug R.M. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Mol Cell 1 7 (1998) 991-1000
6. Qiu Y., and Krug R.M. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol 68 4 (1994) 2425-2432
7. Satterly N., Tsai P.L., van Deursen J., Nussenzveig D.R., Wang Y., Faria P.A., et al. Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci USA 104 6 (2007) 1853-1858
8. Donelan N.R., Basler C.F., and Garcia-Sastre A. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77 24 (2003) 13257-13266
9. Fernandez-Sesma A., Marukian S., Ebersole B.J., Kaminski D., Park M.S., Yuen T., et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 80 13 (2006) 6295-6304
10. Gorse G.J., Campbell M.J., Otto E.E., Powers D.C., Chambers G.W., and Newman F.K. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. J Infect Dis 172 1 (1995) 1-10
11. Nelson K.M., Schram B.R., McGregor M.W., Sheoran A.S., Olsen C.W., and Lunn D.P. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 16 13 (1998) 1306-1313
12. Quinlivan M., Zamarin D., Garcia-Sastre A., Cullinane A., Chambers T., and Palese P. Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 79 13 (2005) 8431-8439
13. Solorzano A., Webby R.J., Lager K.M., Janke B.H., Garcia-Sastre A., and Richt J.A. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol 79 12 (2005) 7535-7543
14. Talon J., Salvatore M., O'Neill R.E., Nakaya Y., Zheng H., Muster T., et al. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci USA 97 8 (2000) 4309-4314
15. Suarez D.L., and Perdue M.L. Multiple alignment comparison of the non-structural genes of influenza A viruses. Virus Res 54 1 (1998) 59-69
16. Norton G.P., Tanaka T., Tobita K., Nakada S., Buonagurio D.A., Greenspan D., et al. Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology 156 2 (1987) 204-213
17. Marcus P.I., Rojek J.M., and Sekellick M.J. Interferon induction and/or production and its suppression by influenza A viruses. J Virol 79 5 (2005) 2880-2890
18. Cauthen A.N., Swayne D.E., Sekellick M.J., Marcus P.I., and Suarez D.L. Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol 81 4 (2007) 1838-1847
19. Swayne DE, Senne, DA. Avian influenza. In: Swayne DE, editors. A laboratory manual for the isolation and identification of avian pathogens American association of avian pathologists. Kennett Square, PA; 1998, p. 150-55.
20. Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 40 9 (2002) 3256-3260
21. Lee C.W., Senne D.A., and Suarez D.L. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (differentiating infected from vaccinated animals) strategy for the control of avian influenza. Vaccine 22 23-24 (2004) 3175-3181
22. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96 16 (1999) 9345-9350
23. Lee C.W., Lee Y.J., Senne D.A., and Suarez D.L. Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics. Virology 353 2 (2006) 388-395
24. Lee C.W., Swayne D.E., Linares J.A., Senne D.A., and Suarez D.L. H5N2 avian influenza outbreak in Texas in 2004: the first highly pathogenic strain in the United States in 20 years?. J Virol 79 17 (2005) 11412-11421
25. Fodor E., Devenish L., Engelhardt O.G., Palese P., Brownlee G.G., and Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol 73 11 (1999) 9679-9682
26. Schat K.A., and Purchase H.G. Cell-culture methods. In: Swayne D.E. (Ed). A laboratory manual for the isolation and identification of avian pathogens (1998), American Association of Avian Pathologists, Kennett Square, PA 223-234
27. Swayne D.E. Pathobiology of H5N2 Mexican avian influenza virus infections of chickens. Vet Pathol 34 6 (1997) 557-567
28. Sekellick M.J., Biggers W.J., and Marcus P.I. Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro. In Vitro Cell Dev Biol 26 10 (1990) 997-1003
29. Diaz M.O., Ziemin S., Le Beau M.M., Pitha P., Smith S.D., Chilcote R.R., et al. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 85 14 (1988) 5259-5263
30. Garcia-Sastre A., Egorov A., Matassov D., Brandt S., Levy D.E., Durbin J.E., et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252 2 (1998) 324-330
31. Winter G., Fields S., Gait M.J., and Brownlee G.G. The use of synthetic oligodeoxynucleotide primers in cloning and sequencing segment of 8 influenza virus (A/PR/8/34). Nucleic Acids Res 9 2 (1981) 237-245
32. Bornholdt Z.A., and Prasad B.V. X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol 13 6 (2006) 559-560
33. Egorov A., Brandt S., Sereinig S., Romanova J., Ferko B., Katinger D., et al. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol 72 8 (1998) 6437-6441
34. Palese P., Muster T., Zheng H., O'Neill R., and Garcia-Sastre A. Learning from our foes: a novel vaccine concept for influenza virus. Arch Virol 15 Suppl. (1999) 131-138
35. Jin H., Zhou H., Lu B., and Kemble G. Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60. J Virol 78 2 (2004) 995-998
36. Song H., Nieto G.R., and Perez D.R. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 81 17 (2007) 9238-9248
37. Ferko B., Kittel C., Romanova J., Sereinig S., Katinger H., and Egorov A. Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts. J Virol 80 23 (2006) 11621-11627
38. Kittel C., Ferko B., Kurz M., Voglauer R., Sereinig S., Romanova J., et al. Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment. J Virol 79 16 (2005) 10672-10677